CL2016002368A1 - Compounds derived from benzamide, inhibitors of wnt signaling pathways; intermediary compounds; compositions and pharmacological combinations; useful for the prevention or treatment of polyposis coli, osteoporosispseudoglioma syndrome, exudative vitreoretinopathy, retinal angiogenesis, early coronary disease, tetra amelia syndrome, type 2 diabetes mellitus, fragile syndrome, solid tumors, among others. - Google Patents
Compounds derived from benzamide, inhibitors of wnt signaling pathways; intermediary compounds; compositions and pharmacological combinations; useful for the prevention or treatment of polyposis coli, osteoporosispseudoglioma syndrome, exudative vitreoretinopathy, retinal angiogenesis, early coronary disease, tetra amelia syndrome, type 2 diabetes mellitus, fragile syndrome, solid tumors, among others.Info
- Publication number
- CL2016002368A1 CL2016002368A1 CL2016002368A CL2016002368A CL2016002368A1 CL 2016002368 A1 CL2016002368 A1 CL 2016002368A1 CL 2016002368 A CL2016002368 A CL 2016002368A CL 2016002368 A CL2016002368 A CL 2016002368A CL 2016002368 A1 CL2016002368 A1 CL 2016002368A1
- Authority
- CL
- Chile
- Prior art keywords
- syndrome
- compounds
- benzamide
- tetra
- inhibitors
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Compuestos derivados de benzamida, inhibidores de las vías de señalización de WNT; compuestos intermediarios; composiciones y combinaciones farmacológicas; útiles para la prevención o tratamiento de poliposis coli, síndrome de osteoporosispseudoglioma, vitreorretinopatía exudativa, angiogénesis retinal, enfermedad coronaria temprana, síndrome tetra Amelia, diabetes mellitus tipo 2, síndrome de frágil, tumores sólidos, entre otras.Compounds derived from benzamide, inhibitors of WNT signaling pathways; intermediary compounds; compositions and pharmacological combinations; useful for the prevention or treatment of polyposis coli, osteoporosispseudoglioma syndrome, exudative vitreoretinopathy, retinal angiogenesis, early coronary disease, tetra Amelia syndrome, type 2 diabetes mellitus, fragile syndrome, solid tumors, among others.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461968172P | 2014-03-20 | 2014-03-20 | |
EP14185274 | 2014-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2016002368A1 true CL2016002368A1 (en) | 2017-03-03 |
Family
ID=65628886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2016002368A CL2016002368A1 (en) | 2014-03-20 | 2016-09-20 | Compounds derived from benzamide, inhibitors of wnt signaling pathways; intermediary compounds; compositions and pharmacological combinations; useful for the prevention or treatment of polyposis coli, osteoporosispseudoglioma syndrome, exudative vitreoretinopathy, retinal angiogenesis, early coronary disease, tetra amelia syndrome, type 2 diabetes mellitus, fragile syndrome, solid tumors, among others. |
Country Status (5)
Country | Link |
---|---|
CL (1) | CL2016002368A1 (en) |
IL (1) | IL247327A0 (en) |
MA (1) | MA39762A (en) |
SV (1) | SV2016005282A (en) |
ZA (1) | ZA201605726B (en) |
-
2015
- 2015-03-18 MA MA039762A patent/MA39762A/en unknown
-
2016
- 2016-08-17 ZA ZA201605726A patent/ZA201605726B/en unknown
- 2016-08-17 IL IL247327A patent/IL247327A0/en unknown
- 2016-09-20 SV SV2016005282A patent/SV2016005282A/en unknown
- 2016-09-20 CL CL2016002368A patent/CL2016002368A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA39762A (en) | 2017-01-25 |
ZA201605726B (en) | 2019-11-27 |
SV2016005282A (en) | 2018-12-05 |
IL247327A0 (en) | 2016-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2019000386A2 (en) | Heterocyclic compounds as immunomodulators | |
CY1121938T1 (en) | 4-HYDROXY-3-(HETERORYL)PYRIDINO-2-ONE APJ AGENTS FOR USE IN THE TREATMENT OF CARDIAC DISORDERS | |
NI201600164A (en) | COMPOUNDS AND COMPOSITIONS AS AGONISTS OF THE TOLL 7 TYPE RECEPTOR | |
DOP2016000271A (en) | FUSIONED BICYCLIC HETEROARILO OR ARILO COMPOUNDS | |
CO2017004525A2 (en) | Ror-gamma inhibitory dihydropyrrolopyridines | |
PH12018502307A1 (en) | Aromatic sulfonamide derivatives | |
CL2018002814A1 (en) | Compositions and methods for the treatment of wounds, disorders, and skin diseases. | |
MX2016014308A (en) | Compounds and compositions as toll-like receptor 7 agonists. | |
CL2015002529A1 (en) | Tetrahydropyrrolothiazine Compounds | |
CL2015000880A1 (en) | Heterocyclic compounds derived from 4-pyrimidinone, hiv reverse transcriptase inhibitors; pharmaceutical composition; use in the prophylaxis or treatment of hiv infection or for the prophylaxis, treatment or delay of the onset of AIDS in a subject. | |
UY39706A (en) | DERIVATIVES OF (1HINDOL-3-IL)-2-(4-CHLORO-2-METHOXY-PHENYL)-2-((3-METHOXY-5-(METHYLSULFONYL) PHENYL)AMINO)ETHANONE AS INHIBITORS OF THE REPLICATION OF THE VIRUS OF THE DENGUE | |
UY37182A (en) | INDOLINA DERIVATIVES REPLACED AS INHIBITORS OF THE VIRAL REPLICATION OF DENGUE | |
CL2015001279A1 (en) | Compounds derived from pyridine, urate transporter inhibitors urat 1; pharmaceutical composition that includes them; use for the treatment or prevention of diseases such as gout, hyperuricemia, hypertension, kidney diseases, among others. | |
CL2017001511A1 (en) | Piperidine derivatives as hdac1 / 2 inhibitors. | |
EA201692091A1 (en) | CHINOXALINE COMPOUNDS AND THEIR APPLICATION | |
EA201790519A1 (en) | THERAPEUTIC CONNECTIONS AS INTEGRATORS OF OREXIN-1 RECEPTOR | |
UY37466A (en) | N-HYDROXIAMIDINHETEROCICLES SUBSTITUTED AS MODULATORS OF INDOLAMINE 2,3-DIOXYGENASE | |
EA201890449A1 (en) | FUMAGILLINUM HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND APPLICATION | |
CL2015003195A1 (en) | Purine derivatives as cb2 receptor agonists. | |
DOP2016000312A (en) | COMPOUNDS DERIVED FROM 1- (CICLOPENT-2-EN-1-IL) -3- (2-HIDROXI-3- (ARILSULFONIL) PHENYL) UREA AS CXCR2 INHIBITORS | |
UY36145A (en) | Compounds of 1, 3, 4-thiadiazole and use thereof for the treatment of cancer | |
CL2018001085A1 (en) | Indolin-2-one derivatives | |
CU20200038A7 (en) | COMPOUNDS DERIVED FROM PYRAZOLO-PIRROLO-PYRIMIDINE-DIONA AS INHIBITORS OF P2X3 | |
CL2016002354A1 (en) | Compounds derived from benzamide with wnt inhibitory activity; intermediary compounds; pharmaceutical composition that includes them; use in the treatment of cancer and other diseases with inappropriate immune response. | |
CL2017000117A1 (en) | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity. |